{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:44:00Z","timestamp":1792557840190,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T00:00:00Z","timestamp":1580860800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T00:00:00Z","timestamp":1580860800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1092788"],"award-info":[{"award-number":["1092788"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1084178"],"award-info":[{"award-number":["1084178"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012737","name":"Department of Health and Human Services, State Government of Victoria","doi-asserted-by":"publisher","award":["CRE in Brain Cancer"],"award-info":[{"award-number":["CRE in Brain Cancer"]}],"id":[{"id":"10.13039\/100012737","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s00259-020-04706-0","type":"journal-article","created":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T23:02:30Z","timestamp":1580943750000},"page":"1476-1485","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Spatial and quantitative mapping of glycolysis and hypoxia in glioblastoma as a predictor of radiotherapy response and sites of relapse"],"prefix":"10.1007","volume":"47","author":[{"given":"Antoine","family":"Leimgruber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Hickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sze Ting","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui K","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence M","family":"Cher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John I","family":"Sachinidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme J","family":"O\u2019Keefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6656-295X","authenticated-orcid":false,"given":"Andrew M","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,5]]},"reference":[{"key":"4706_CR1","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987\u201396. https:\/\/doi.org\/10.1056\/NEJMoa043330.","journal-title":"N Engl J Med"},{"key":"4706_CR2","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.2967\/jnumed.106.037689","volume":"48","author":"W Chen","year":"2007","unstructured":"Chen W. Clinical applications of PET in brain tumors. J Nucl Med. 2007;48:1468\u201381. https:\/\/doi.org\/10.2967\/jnumed.106.037689.","journal-title":"J Nucl Med"},{"key":"4706_CR3","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.2967\/jnumed.111.098590","volume":"53","author":"N Galldiks","year":"2012","unstructured":"Galldiks N, Langen KJ, Holy R, Pinkawa M, Stoffels G, Nolte KW, et al. Assessment of treatment response in patients with glioblastoma using O-(2-18F-fluoroethyl)-L-tyrosine PET in comparison to MRI. J Nucl Med. 2012;53:1048\u201357. https:\/\/doi.org\/10.2967\/jnumed.111.098590.","journal-title":"J Nucl Med"},{"key":"4706_CR4","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1085\/jgp.8.6.519","volume":"8","author":"O Warburg","year":"1927","unstructured":"Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. J Gen Physiol. 1927;8:519\u201330. https:\/\/doi.org\/10.1085\/jgp.8.6.519.","journal-title":"J Gen Physiol"},{"key":"4706_CR5","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1259\/0007-1285-26-312-638","volume":"26","author":"LH Gray","year":"1953","unstructured":"Gray LH, Conger AD, Ebert M, Hornsey S, Scott OC. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol. 1953;26:638\u201348. https:\/\/doi.org\/10.1259\/0007-1285-26-312-638.","journal-title":"Br J Radiol"},{"key":"4706_CR6","doi-asserted-by":"publisher","first-page":"8980","DOI":"10.1158\/0008-5472.CAN-07-0895","volume":"67","author":"JN Rich","year":"2007","unstructured":"Rich JN. Cancer stem cells in radiation resistance. Cancer Res. 2007;67:8980\u20134. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-0895.","journal-title":"Cancer Res"},{"key":"4706_CR7","doi-asserted-by":"publisher","unstructured":"Monteiro AR, Hill R, Pilkington GJ, Madureira PA. the role of hypoxia in glioblastoma invasion. Cells. 2017;6. https:\/\/doi.org\/10.3390\/cells6040045.","DOI":"10.3390\/cells6040045"},{"key":"4706_CR8","doi-asserted-by":"publisher","first-page":"38908","DOI":"10.18632\/oncotarget.7676","volume":"7","author":"L Yu","year":"2016","unstructured":"Yu L, Chen X, Wang L, Chen S. The sweet trap in tumors: aerobic glycolysis and potential targets for therapy. Oncotarget. 2016;7:38908\u201326. https:\/\/doi.org\/10.18632\/oncotarget.7676.","journal-title":"Oncotarget"},{"key":"4706_CR9","first-page":"407","volume":"19","author":"PE Ricci","year":"1998","unstructured":"Ricci PE, Karis JP, Heiserman JE, Fram EK, Bice AN, Drayer BP. Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography? AJNR Am J Neuroradiol. 1998;19:407\u201313.","journal-title":"AJNR Am J Neuroradiol"},{"key":"4706_CR10","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1053\/j.semnuclmed.2007.07.001","volume":"37","author":"ST Lee","year":"2007","unstructured":"Lee ST, Scott AM. Hypoxia positron emission tomography imaging with 18f-fluoromisonidazole. Semin Nucl Med. 2007;37:451\u201361. https:\/\/doi.org\/10.1053\/j.semnuclmed.2007.07.001.","journal-title":"Semin Nucl Med"},{"key":"4706_CR11","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1053\/j.semnuclmed.2014.10.001","volume":"45","author":"C Bell","year":"2015","unstructured":"Bell C, Dowson N, Fay M, Thomas P, Puttick S, Gal Y, et al. Hypoxia imaging in gliomas with 18F-fluoromisonidazole PET: toward clinical translation. Semin Nucl Med. 2015;45:136\u201350. https:\/\/doi.org\/10.1053\/j.semnuclmed.2014.10.001.","journal-title":"Semin Nucl Med"},{"key":"4706_CR12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fmed.2019.00117.","volume":"6","author":"M Gerard","year":"2019","unstructured":"Gerard M, Corroyer-Dulmont A, Lesueur P, Collet S, Cherel M, Bourgeois M, et al. Hypoxia imaging and adaptive radiotherapy: a state-of-the-art approach in the management of glioma. Front Med (Lausanne). 2019;6:117. https:\/\/doi.org\/10.3389\/fmed.2019.00117.","journal-title":"Front Med (Lausanne)"},{"key":"4706_CR13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12885-019-5317-x","volume":"19","author":"A Laprie","year":"2019","unstructured":"Laprie A, Ken S, Filleron T, Lubrano V, Vieillevigne L, Tensaouti F, et al. Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging. BMC Cancer. 2019;19:167. https:\/\/doi.org\/10.1186\/s12885-019-5317-x.","journal-title":"BMC Cancer"},{"key":"4706_CR14","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/0969-8043(93)90110-V","volume":"44","author":"JL Lim","year":"1993","unstructured":"Lim JL, Berridge MS. An efficient radiosynthesis of [18F]fluoromisonidazole. Appl Radiat Isot. 1993;44:1085\u201391.","journal-title":"Appl Radiat Isot"},{"key":"4706_CR15","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1200\/JCO.1990.8.7.1277","volume":"8","author":"DR Macdonald","year":"1990","unstructured":"Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol. 1990;8:1277\u201380. https:\/\/doi.org\/10.1200\/JCO.1990.8.7.1277.","journal-title":"J Clin Oncol"},{"key":"4706_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10278-004-1014-6","volume":"17","author":"A Rosset","year":"2004","unstructured":"Rosset A, Spadola L, Ratib O. OsiriX: an open-source software for navigating in multidimensional DICOM images. J Digit Imaging. 2004;17:205\u201316. https:\/\/doi.org\/10.1007\/s10278-004-1014-6.","journal-title":"J Digit Imaging"},{"key":"4706_CR17","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1109\/TMI.2009.2035616","volume":"29","author":"S Klein","year":"2010","unstructured":"Klein S, Staring M, Murphy K, Viergever MA, Pluim JP. elastix: a toolbox for intensity-based medical image registration. IEEE Trans Med Imaging. 2010;29:196\u2013205. https:\/\/doi.org\/10.1109\/TMI.2009.2035616.","journal-title":"IEEE Trans Med Imaging"},{"key":"4706_CR18","first-page":"410","volume":"47","author":"LM Cher","year":"2006","unstructured":"Cher LM, Murone C, Lawrentschuk N, Ramdave S, Papenfuss A, Hannah A, et al. Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies. J Nucl Med. 2006;47:410\u20138.","journal-title":"J Nucl Med"},{"key":"4706_CR19","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3389\/fonc.2019.00374","volume":"9","author":"A Chaddad","year":"2019","unstructured":"Chaddad A, Kucharczyk MJ, Daniel P, Sabri S, Jean-Claude BJ, Niazi T, et al. Radiomics in glioblastoma: current status and challenges facing clinical implementation. Front Oncol. 2019;9:374. https:\/\/doi.org\/10.3389\/fonc.2019.00374.","journal-title":"Front Oncol"},{"key":"4706_CR20","doi-asserted-by":"publisher","unstructured":"Shaver MM, Kohanteb PA, Chiou C, Bardis MD, Chantaduly C, Bota D, et al. Optimizing neuro-oncology imaging: a review of deep learning approaches for glioma imaging. Cancers (Basel). 2019;11. doi:https:\/\/doi.org\/10.3390\/cancers11060829.","DOI":"10.3390\/cancers11060829."},{"key":"4706_CR21","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1158\/1078-0432.CCR-17-2236","volume":"24","author":"K Chang","year":"2018","unstructured":"Chang K, Bai HX, Zhou H, Su C, Bi WL, Agbodza E, et al. Residual convolutional neural network for the determination of IDH status in low- and high-grade gliomas from MR imaging. Clin Cancer Res. 2018;24:1073\u201381. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-2236.","journal-title":"Clin Cancer Res"},{"key":"4706_CR22","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.3174\/ajnr.A5667","volume":"39","author":"P Chang","year":"2018","unstructured":"Chang P, Grinband J, Weinberg BD, Bardis M, Khy M, Cadena G, et al. Deep-learning convolutional neural networks accurately classify genetic mutations in gliomas. AJNR Am J Neuroradiol. 2018;39:1201\u20137. https:\/\/doi.org\/10.3174\/ajnr.A5667.","journal-title":"AJNR Am J Neuroradiol"},{"key":"4706_CR23","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1088\/0031-9155\/52\/12\/010","volume":"52","author":"M Hatt","year":"2007","unstructured":"Hatt M, Lamare F, Boussion N, Turzo A, Collet C, Salzenstein F, et al. Fuzzy hidden Markov chains segmentation for volume determination and quantitation in PET. Phys Med Biol. 2007;52:3467\u201391. https:\/\/doi.org\/10.1088\/0031-9155\/52\/12\/010.","journal-title":"Phys Med Biol"},{"key":"4706_CR24","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2967\/jnumed.108.055467","volume":"50","author":"KR Swanson","year":"2009","unstructured":"Swanson KR, Chakraborty G, Wang CH, Rockne R, Harpold HL, Muzi M, et al. Complementary but distinct roles for MRI and 18F-fluoromisonidazole PET in the assessment of human glioblastomas. J Nucl Med. 2009;50:36\u201344. https:\/\/doi.org\/10.2967\/jnumed.108.055467.","journal-title":"J Nucl Med"},{"key":"4706_CR25","doi-asserted-by":"publisher","first-page":"e194","DOI":"10.1097\/RLU.0b013e3182335e20","volume":"36","author":"H De Clermont","year":"2011","unstructured":"De Clermont H, Huchet A, Lamare F, Riviere A, Fernandez P. Lack of concordance between the F-18 fluoromisonidazole PET and the F-18 FDG PET in human glioblastoma. Clin Nucl Med. 2011;36:e194\u20135. https:\/\/doi.org\/10.1097\/RLU.0b013e3182335e20.","journal-title":"Clin Nucl Med"},{"key":"4706_CR26","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1158\/1078-0432.CCR-0688-3","volume":"10","author":"JG Rajendran","year":"2004","unstructured":"Rajendran JG, Mankoff DA, O\u2019Sullivan F, Peterson LM, Schwartz DL, Conrad EU, et al. Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging. Clin Cancer Res. 2004;10:2245\u201352.","journal-title":"Clin Cancer Res"},{"key":"4706_CR27","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1007\/s00259-006-0175-6","volume":"33","author":"M Zimny","year":"2006","unstructured":"Zimny M, Gagel B, DiMartino E, Hamacher K, Coenen HH, Westhofen M, et al. FDG--a marker of tumour hypoxia? A comparison with [18F]fluoromisonidazole and pO2-polarography in metastatic head and neck cancer. Eur J Nucl Med Mol Imaging. 2006;33:1426\u201331. https:\/\/doi.org\/10.1007\/s00259-006-0175-6.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4706_CR28","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1158\/1078-0432.CCR-07-4995","volume":"14","author":"AM Spence","year":"2008","unstructured":"Spence AM, Muzi M, Swanson KR, O\u2019Sullivan F, Rockhill JK, Rajendran JG, et al. Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival. Clin Cancer Res. 2008;14:2623\u201330. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-4995.","journal-title":"Clin Cancer Res"},{"key":"4706_CR29","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/j.ijrobp.2010.12.074","volume":"82","author":"KC Cuneo","year":"2012","unstructured":"Cuneo KC, Vredenburgh JJ, Sampson JH, Reardon DA, Desjardins A, Peters KB, et al. Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys. 2012;82:2018\u201324. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.12.074.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4706_CR30","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s00066-009-1965-0","volume":"185","author":"MG Fabrini","year":"2009","unstructured":"Fabrini MG, Perrone F, De Franco L, Pasqualetti F, Grespi S, Vannozzi R, et al. Perioperative high-dose-rate brachytherapy in the treatment of recurrent malignant gliomas. Strahlenther Onkol. 2009;185:524\u20139. https:\/\/doi.org\/10.1007\/s00066-009-1965-0.","journal-title":"Strahlenther Onkol"},{"key":"4706_CR31","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1600-0404.2010.01350.x","volume":"122","author":"R Helseth","year":"2010","unstructured":"Helseth R, Helseth E, Johannesen TB, Langberg CW, Lote K, Ronning P, et al. Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme. Acta Neurol Scand. 2010;122:159\u201367. https:\/\/doi.org\/10.1111\/j.1600-0404.2010.01350.x.","journal-title":"Acta Neurol Scand"},{"key":"4706_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s11060-008-9752-9","volume":"92","author":"M Patel","year":"2009","unstructured":"Patel M, Siddiqui F, Jin JY, Mikkelsen T, Rosenblum M, Movsas B, et al. Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival. J Neuro-Oncol. 2009;92:185\u201391. https:\/\/doi.org\/10.1007\/s11060-008-9752-9.","journal-title":"J Neuro-Oncol"},{"key":"4706_CR33","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10143-009-0212-6","volume":"32","author":"AT Villavicencio","year":"2009","unstructured":"Villavicencio AT, Burneikiene S, Romanelli P, Fariselli L, McNeely L, Lipani JD, et al. Survival following stereotactic radiosurgery for newly diagnosed and recurrent glioblastoma multiforme: a multicenter experience. Neurosurg Rev. 2009;32:417\u201324. https:\/\/doi.org\/10.1007\/s10143-009-0212-6.","journal-title":"Neurosurg Rev"},{"key":"4706_CR34","first-page":"945","volume":"46","author":"W Chen","year":"2005","unstructured":"Chen W, Cloughesy T, Kamdar N, Satyamurthy N, Bergsneider M, Liau L, et al. Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG. J Nucl Med. 2005;46:945\u201352.","journal-title":"J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-020-04706-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-020-04706-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-020-04706-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:14:32Z","timestamp":1612397672000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-020-04706-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,5]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["4706"],"URL":"https:\/\/doi.org\/10.1007\/s00259-020-04706-0","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,5]]},"assertion":[{"value":"9 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patients provided written informed consent. Patients with previous history of glioma and\/or brain radiotherapy were excluded. The study was approved by the Austin Health\u2019s Human Research Ethics Committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}